Open Access & Peer-Reviewed
Submit ManuscriptIJCP welcomes qualified researchers and clinicians to join the reviewer panel. Reviewers strengthen the quality and credibility of published chemotherapy research.
Reviewer appointments are based on expertise, publication record, and coverage needs within the journal scope.
A diverse reviewer community supports balanced evaluation across tumor types and methodological approaches.
Submit your CV, areas of expertise, and recent publications. Reviewer invitations are based on topic fit and coverage needs.
We aim to match reviewers to manuscripts that align with their specialization to ensure meaningful and efficient evaluations.
Maintaining an updated profile helps the editorial team assign reviews that match your expertise.
Reviewers are typically invited based on specific manuscript topics and availability at the time of review.
Profiles should highlight methodological expertise, statistical skills, and clinical focus areas to support precise matching.
Include experience with clinical trials, drug development, or supportive care research to improve assignment relevance.
Indicate language proficiency and preferred review volume to improve matching and ensure timely invitations. Update your profile annually to keep details current. We welcome diverse expertise.
Active researchers or clinicians with peer reviewed publications.
List subspecialties to match review assignments.
Indicate expected review capacity and preferred timelines.
Strong publication record in oncology or pharmacology.
Clear and constructive feedback history.
Commitment to confidentiality and ethics.
Ability to complete reviews on schedule.
Alignment with chemotherapy research topics and methods.
Experience with clinical trials, translational studies, or pharmacology preferred.
Reviewer roles are based on expertise and availability.
Clear review standards and templates.
Reasonable deadlines with extension options.
Editorial office available for questions.
Assignments aligned with reviewer expertise.
Join the IJCP reviewer panel today.
